---  
layout: startup_page  
title: "nChroma Bio"  
id: "nchromabio.com"  
permalink: "/nchromabionchromabio.com12112024/"  
website: "https://www.nchromabio.com/"  
funding_round: ""  
funding_amount: "$75M"  
investors: "Cormorant Asset Management, ARCH Venture Partners, Atlas Venture, Newpath Partners, 5AM Ventures, DCVC Bio, F-Prime Capital, GV (Google Ventures), Janus Henderson Investors, Mubadala Capital, Omega Funds, Sixth Street, Sofinnova Partners, T. Rowe Price, Wellington Management, Alexandria Venture Investments, Casdin Capital, Menlo Ventures, Wilson Sonsini Goodrich & Rosati"  
about: "nChroma Bio is a biotechnology company focused on developing in vivo targeted genetic medicines. Their integrated platform combines epigenetic editing with non-viral delivery to address limitations in current genetic medicine approaches, expanding the scope of treatable diseases. Their lead candidate, CRMA-1001, targets chronic hepatitis B and D."  
markets: "Biotechnology, Genetic Medicine, Epigenetics"  
hq: "Boston, Massachusetts, United States"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/nchroma-bio"  
twitter: "https://twitter.com/nchromabio"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nchroma-bio"  
pitchbook: "https://pitchbook.com/profiles/company/720091-63"  

date_display: "11-Dec-2024"  
date: "2024-12-11"

# SEO Optimization  
meta_title: "nChroma Bio -  Funding ($75M)"  
meta_description: "nChroma Bio, nChroma Bio is a biotechnology company focused on developing in vivo targeted genetic medicines. Their integrated platform combines epigenetic editing..."  
meta_keywords: "nChroma Bio, Biotechnology, Genetic Medicine, Epigenetics,  funding"  
canonical_url: "https://startup.projectstartups.com/nchromabionchromabio.com12112024/"  
---